Inhibrx Biosciences, Inc. (INBX)
90.53
-4.48
(-4.72%)
USD |
NASDAQ |
Oct 12, 16:00
90.46
-0.07
(-0.08%)
After-Hours: 20:00
Inhibrx Biosciences Price : 90.53 for Oct. 12, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 12, 2026 | 94.03 | 96.10 | 90.00 | 90.53 | 216103.0 |
| Oct 09, 2026 | 92.70 | 95.81 | 92.70 | 95.01 | 86819.00 |
| Oct 08, 2026 | 93.14 | 93.28 | 90.15 | 92.76 | 208039.0 |
| Oct 07, 2026 | 92.02 | 96.71 | 90.66 | 93.36 | 223780.0 |
| Oct 06, 2026 | 95.52 | 96.96 | 92.60 | 93.41 | 169451.0 |
| Oct 05, 2026 | 97.56 | 98.51 | 94.18 | 94.56 | 207091.0 |
| Oct 02, 2026 | 99.30 | 100.12 | 96.07 | 96.99 | 201447.0 |
| Oct 01, 2026 | 100.71 | 102.16 | 97.58 | 97.93 | 216611.0 |
| Sep 30, 2026 | 105.67 | 106.94 | 100.08 | 100.08 | 389480.0 |
| Sep 29, 2026 | 105.31 | 107.90 | 102.51 | 104.83 | 240935.0 |
| Sep 28, 2026 | 98.69 | 104.55 | 98.51 | 101.71 | 188883.0 |
| Sep 25, 2026 | 101.29 | 101.29 | 98.09 | 99.61 | 158659.0 |
| Sep 24, 2026 | 102.38 | 104.49 | 99.53 | 100.40 | 285794.0 |
| Sep 23, 2026 | 110.12 | 110.88 | 98.56 | 100.33 | 375303.0 |
| Sep 22, 2026 | 112.45 | 117.14 | 109.05 | 110.67 | 292151.0 |
| Sep 21, 2026 | 112.69 | 113.18 | 108.94 | 112.04 | 249134.0 |
| Sep 18, 2026 | 106.45 | 110.41 | 105.04 | 109.35 | 483377.0 |
| Sep 17, 2026 | 103.73 | 108.00 | 103.73 | 104.73 | 217279.0 |
| Sep 16, 2026 | 105.61 | 106.44 | 99.06 | 101.77 | 363492.0 |
| Sep 15, 2026 | 109.44 | 109.44 | 104.84 | 105.61 | 251603.0 |
| Sep 14, 2026 | 109.10 | 111.44 | 104.90 | 110.47 | 239992.0 |
| Sep 11, 2026 | 113.00 | 115.11 | 108.93 | 109.27 | 211017.0 |
| Sep 10, 2026 | 109.23 | 113.95 | 107.22 | 111.42 | 313889.0 |
| Sep 09, 2026 | 117.38 | 128.54 | 112.03 | 112.86 | 677825.0 |
| Sep 08, 2026 | 117.22 | 120.18 | 94.00 | 114.34 | 1.677M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Agenus, Inc. | 7.43 |
| Amgen, Inc. | 417.57 |
| Anika Therapeutics, Inc. | 20.47 |
| BioCryst Pharmaceuticals, Inc. | 8.36 |
| Imunon, Inc. | 1.07 |
Price Related Metrics
| Earnings Yield | -9.80% |
| Market Cap | 1.332B |